Links To And Excerpts From “2022 ACC Expert Consensus Decision Pathway on the Role of Nonstatin Therapies for LDL-Cholesterol Lowering in the Management of Atherosclerotic Cardiovascular Disease Risk: A Report of the American College of Cardiology Solution Set Oversight Committee”

Posted on November 10, 2023 by Tom Wade MD

Today, I reviewed, linked to, and excerpt from 2022 ACC Expert Consensus Decision Pathway on the Role of Nonstatin Therapies for LDL-Cholesterol Lowering in the Management of Atherosclerotic Cardiovascular Disease Risk: A Report of the American College of Cardiology Solution Set Oversight Committee [PubMed Abstract] [Full-Text HTML] [Full-Text PDF]. J Am Coll Cardiol. 2022 Oct 4;80(14):1366-1418. doi: 10.1016/j.jacc.2022.07.006. Epub 2022 Aug 25.

All that follows is from the above resource.

Outline

  1. Key Words
  2. Solution Set Oversight Committee
  3. Table of Contents
  4. Preface
  5. 1. Introduction
  6. 2. Methods
  7. 3. Assumptions and Definitions
  8. 4. Pathway Summary Graphic
  9. 5. Description and Rationale: Approach to Patient Groups Who May Be Considered for Additional Therapy
  10. 6. Conclusions
  11. President and Staff
  12. Appendix
  13. Appendix 1. Author Relationships With Industry and Other Entities (Relevant)— 2022 ACC Expert Consensus Decision Pathway on the Role of Nonstatin Therapies for LDL-Cholesterol Lowering in the Management of Atherosclerotic Cardiovascular Disease Risk
  14. Appendix 2. Peer Reviewer Relationships With Industry and Other Entities (Comprehensive)—2022 ACC Expert Consensus Decision Pathway on the Role of Nonstatin Therapies for LDL-Cholesterol Lowering in the Management of Atherosclerotic Cardiovascular Disease Risk
  15. Appendix 3. Abbreviations
  16. References

3. ASSUMPTIONS AND DEFINITIONS

Start here.

 

 

This entry was posted in American College Of Cardiology, American College Of Cardiology Guidelines, Medical News. Bookmark the permalink.